Autoimmune Encephalitis chest x ray

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Julinka Auta Fernandes

Autoimmune Encephalitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Autoimmune Encephalitis from Other Conditions

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Clinical Diagnostic Criteria

Antibody-Negative Autoimmune Encephalitis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography or Ultrasound

CT Scan

MRI

Other Imaging Findings

Electroencephalography

Other Diagnostic Studies

Screening for an Associated Neoplasm

Pediatric Considerations

Treatment

Medical Therapy

Symptomatic and Supportive Therapy

Interventions

Surgery

Pediatric Treatment Considerations

Rehabilitation

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Autoimmune Encephalitis On the Web

Most Recent Articles

Google Scholar Articles

Review Articles

Published Guidelines and Consensus Statements

2016 Clinical Diagnostic Criteria

2024 Canadian Adult Consensus Guidelines

2026 UK Adult Encephalitis Guidelines

Pediatric Diagnostic Recommendations

Pediatric NMDAR Treatment Consensus

CME Resources

PowerPoint Slides

Images

MRI Images

Clinical Trials

NICE Search

FDA Resources

CDC Resources

Autoimmune Encephalitis in the News

Hospitals and Neurology Services

Risk Factors and Prognosis Studies

Overview

Autoimmune encephalitis has no characteristic chest X-ray finding, and chest radiography cannot establish or exclude the neurological diagnosis. Its role is to investigate associated thoracic disease or suspected respiratory complications when clinically indicated.[1]

A normal chest X-ray does not exclude an underlying lung cancer or thymoma. Chest radiography must not replace appropriate tumor screening with computed tomography (CT) and other investigations selected according to the patient's age, clinical syndrome, antibody results, and cancer risk.[2][3]

Key Chest X-Ray Findings in Autoimmune Encephalitis

In autoimmune encephalitis, an abnormal chest X-ray generally reflects an associated condition or complication rather than the autoimmune brain inflammation itself.

Associated condition Possible chest X-ray findings Interpretation
Intrathoracic tumor A visible pulmonary mass or mediastinal widening may raise suspicion of an underlying tumor. These findings are not specific for autoimmune encephalitis. Small or occult tumors may not be visible; suspicious findings require further investigation, usually with CT.[2]
Pneumonia Focal or multifocal pulmonary opacities or consolidation; a pleural effusion may accompany complicated pneumonia. Interpret alongside symptoms, examination, oxygenation, and laboratory results. The radiograph alone does not identify the organism or establish that aspiration caused the abnormality.[4]
No identifiable thoracic abnormality The chest X-ray may be normal. A normal radiograph neither excludes autoimmune encephalitis nor completes screening for an associated neoplasm.[1][2]

Investigation of Respiratory Complications

In autoimmune encephalitis, chest radiography may be appropriate when new respiratory symptoms or signs suggest pneumonia or another pulmonary complication, particularly with fever, cough, hypoxemia, or abnormal respiratory examination findings. Imaging should answer a clinical question rather than serve as a diagnostic test for autoimmune encephalitis.[4]

Severe autoimmune encephalitis can also cause hypoventilation through brainstem involvement, associated neuromuscular disease, or medication effects. Respiratory compromise therefore requires clinical assessment and monitoring even when chest imaging does not explain its severity; a normal chest radiograph does not demonstrate adequate ventilation.[1]

Role in Tumor Screening

In autoimmune encephalitis, the 2024 Canadian adult consensus guidelines recommend neoplasm screening at the initial presentation without waiting for neural antibody results. Conventional body CT, directed breast or pelvic/testicular imaging, and selected whole-body positron emission tomography form the screening approach.[3]

The 2021 acute-management recommendations describe contrast-enhanced CT of the chest, abdomen, and pelvis as a reasonable initial approach in appropriate adults. Investigation must be individualized when CT or iodinated contrast is unsuitable, including in children and pregnancy.[1]

A normal chest X-ray must not be used to stop an otherwise indicated tumor investigation. The need for subsequent screening depends on antibody-associated risk, clinical phenotype, treatment response, relapse, and other cancer risk factors; repeated chest X-rays alone are not an adequate surveillance strategy.[3][2]

References

  1. ↑ 1.0 1.1 1.2 1.3 Abboud H, Probasco JC, Irani S, et al. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. Journal of Neurology, Neurosurgery & Psychiatry. 2021;92(7):757–768. doi:10.1136/jnnp-2020-325300. PMID:33649022.
  2. ↑ 2.0 2.1 2.2 2.3 Titulaer MJ, Soffietti R, Dalmau J, et al.; European Federation of Neurological Societies. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. European Journal of Neurology. 2011;18(1):19–e3. doi:10.1111/j.1468-1331.2010.03220.x. PMID:20880069.
  3. ↑ 3.0 3.1 3.2 Hahn C, Budhram A, Alikhani K, et al. Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults. Canadian Journal of Neurological Sciences. 2024;51(6):734–754. doi:10.1017/cjn.2024.16. PMID:38312020.
  4. ↑ 4.0 4.1 American College of Radiology. ACR Appropriateness Criteria: Acute Respiratory Illness in Immunocompetent Patients. Revised 2024. See also ACR Appropriateness Criteria Acute Respiratory Illness in Immunocompetent Patients: 2024 Update, published 2025. PMID:40409874.